发明名称 NOVEL COMPOUNDS
摘要 Compounds of formula (I); wherein R1 and R2 are the same or different and may be selected from the group consisting of a hydrogen atom, a hydroxy group, an alkyl group, a halogen atom, an alkoxy group, an acyloxy group, an acyl group, an alkenyl group, an alkynyl group, an aryl group, an alkylthio group, an alkoxycarbonyl group, an alkylsulfinyl group, an alkylsulfonyl group, an amino group, and an alkylamino group; and X represents a carboxylic acid group, a carboxylate group, or a carboxamide group; or any pharmaceutically acceptable salt, solvate, complex or pro-drug thereof, with the provisos that the compound of formula (I) is not (all-Z)-4,7,10,13,16,19-docosahexaenoic acid (DHA), alpha-methyl DHA, alpha-methyl DHA methyl ester, alpha-methyl DHA ethyl ester or alpha-hydroxy DHA ethyl ester, are disclosed. A fatty acid composition and a pharmaceutical composition comprising such compounds are also disclosed. The use of such compounds as medicaments, in particular for the treatment of diabetes type 2, is also disclosed.
申请公布号 US2012065260(A1) 申请公布日期 2012.03.15
申请号 US201113225855 申请日期 2011.09.06
申请人 BRYHN MORTEN;KOPECKY JAN;HOLMEIDE ANNE KRISTIN;PRONOVA BIOPHRMA NORGE AS 发明人 BRYHN MORTEN;KOPECKY JAN;HOLMEIDE ANNE KRISTIN
分类号 A61K31/232;A61K31/202;A61P3/04;A61P3/06;A61P3/10;A61P29/00;C07C51/347 主分类号 A61K31/232
代理机构 代理人
主权项
地址